• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠-胰岛轴的紊乱。

Disturbances of the entero-insular axis.

作者信息

Creutzfeldt W, Ebert R, Nauck M, Stöckmann F

出版信息

Scand J Gastroenterol Suppl. 1983;82:111-9.

PMID:6356314
Abstract

The entero-insular axis comprises direct substrate stimulation of the islet cells by the absorbed nutrients and signal transmission by endocrine factors and nerves. The extent of neural influences has not yet been evaluated. GIP is the main incretin candidate. GIP release is dependent on nutrient absorption. Therefore, GIP abnormalities occur in a large number of gastrointestinal and metabolic diseases. These secondary changes are rarely of clinical significance. GIP hypersecretion may, however, contribute to the increased lipogenesis in obesity and the hypoglycemia in the late dumping syndrome. In type II diabetes hyper- and hyposecretion of GIP has been found but no correlation between GIP and insulin response. GIP abnormalities are not identical with disturbances of the entero-insular axis. These can only be evaluated by estimating the incretin effect (comparing the insulin response to oral glucose with the insulin response to an isoglycaemic iv glucose infusion). A decreased incretin effect has been observed in patients with jejuno-ileal bypass and in type II diabetes. In neither condition was a correlation found between incretin effect and GIP response. It is concluded that disturbances of the entero-insular axis are rarely explained by GIP abnormalities. Therefore, other humoral gut factors must exist. Also the neural part of the entero-insular axis requires exploration in health and disease.

摘要

肠-胰岛轴包括吸收的营养物质对胰岛细胞的直接底物刺激以及内分泌因子和神经的信号传递。神经影响的程度尚未得到评估。胃抑肽是主要的肠促胰岛素候选物。胃抑肽的释放取决于营养物质的吸收。因此,胃抑肽异常发生在大量胃肠道和代谢性疾病中。这些继发性变化很少具有临床意义。然而,胃抑肽分泌过多可能导致肥胖时脂肪生成增加以及晚期倾倒综合征时低血糖。在2型糖尿病中,已发现胃抑肽分泌过多和过少,但胃抑肽与胰岛素反应之间无相关性。胃抑肽异常与肠-胰岛轴紊乱并不相同。这些只能通过评估肠促胰岛素效应(比较口服葡萄糖的胰岛素反应与等血糖静脉注射葡萄糖的胰岛素反应)来评估。在空肠回肠旁路术患者和2型糖尿病患者中观察到肠促胰岛素效应降低。在这两种情况下,均未发现肠促胰岛素效应与胃抑肽反应之间存在相关性。得出的结论是,肠-胰岛轴紊乱很少由胃抑肽异常来解释。因此,必定存在其他体液性肠道因子。肠-胰岛轴的神经部分在健康和疾病状态下也需要探索。

相似文献

1
Disturbances of the entero-insular axis.肠-胰岛轴的紊乱。
Scand J Gastroenterol Suppl. 1983;82:111-9.
2
[Physiology and pathology of the entero-insular axis].
Schweiz Med Wochenschr. 1985 Jul 20;115(29):970-3.
3
Gastric inhibitory polypeptide.胃抑制性多肽
Clin Gastroenterol. 1980 Sep;9(3):679-98.
4
New developments in the incretin concept.肠促胰岛素概念的新进展。
Diabetologia. 1985 Aug;28(8):565-73. doi: 10.1007/BF00281990.
5
GIP and the entero-insular axis.
Clin Endocrinol Metab. 1979 Jul;8(2):365-77. doi: 10.1016/s0300-595x(79)80047-x.
6
Gastrointestinal peptides--rôle in pathophysiology and disease.胃肠肽——在病理生理学和疾病中的作用
Scand J Gastroenterol Suppl. 1982;77:7-20.
7
The incretin concept today.当今的肠促胰岛素概念。
Diabetologia. 1979 Feb;16(2):75-85. doi: 10.1007/BF01225454.
8
Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.2型糖尿病患者一级亲属口服葡萄糖后肠促胰岛素激素(GIP和GLP-1)的分泌及肠促胰岛素效应
Regul Pept. 2004 Nov 15;122(3):209-17. doi: 10.1016/j.regpep.2004.06.020.
9
Clinical aspects of GIP secretion.胃抑肽分泌的临床方面。
Acta Diabetol Lat. 1982 Jan-Mar;19(1):1-11. doi: 10.1007/BF02581180.
10
The ageing entero-insular axis.衰老的肠-胰岛轴
Diabetologia. 1998 Nov;41(11):1309-13. doi: 10.1007/s001250051070.

引用本文的文献

1
Alterations in pancreatic β cell function and Trypanosoma cruzi infection: evidence from human and animal studies.胰腺β细胞功能改变与克氏锥虫感染:来自人类和动物研究的证据。
Parasitol Res. 2017 Mar;116(3):827-838. doi: 10.1007/s00436-016-5350-5. Epub 2016 Dec 24.
2
Exenatide Use in the Management of Type 2 Diabetes Mellitus.艾塞那肽在2型糖尿病管理中的应用
Pharmaceuticals (Basel). 2010 Aug 11;3(8):2554-2567. doi: 10.3390/ph3082554.
3
Incretins and the development of type 2 diabetes.肠促胰岛素与2型糖尿病的发展
Curr Diab Rep. 2006 Jun;6(3):194-201. doi: 10.1007/s11892-006-0034-7.
4
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.2型糖尿病患者中胰高血糖素样肽1[7-36酰胺]的肠促胰岛素活性得以保留,但合成人胃抑制多肽的肠促胰岛素活性未保留。
J Clin Invest. 1993 Jan;91(1):301-7. doi: 10.1172/JCI116186.
5
New developments in the incretin concept.肠促胰岛素概念的新进展。
Diabetologia. 1985 Aug;28(8):565-73. doi: 10.1007/BF00281990.
6
Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man.
Dig Dis Sci. 1987 Feb;32(2):139-44. doi: 10.1007/BF01297101.
7
Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.2型(非胰岛素依赖型)糖尿病患者肠促胰岛素效应降低。
Diabetologia. 1986 Jan;29(1):46-52. doi: 10.1007/BF02427280.